Top News
Latest News
PARTNERSHIPS
8 Dec 2025
Can BioNTech’s CureVac Deal Spark a Biotech Revival?PARTNERSHIPS
3 Dec 2025
A Power Partnership Pushes Europe’s mRNA AmbitionsMARKET TRENDS
24 Oct 2025
From Covid to Cancer, Europe’s mRNA Strategy Takes ShapeINSIGHTS
25 Sep 2025
UK mRNA Hub Signals a New Chapter for Biotech Growth
A Faster Future for mRNA, Powered by AI
INNOVATION
31 Aug 2025
GEMORNA advances mRNA design with AI and shows strong gains in early research
TECHNOLOGY
2 Aug 2025
How Lipid Engineering Is Becoming mRNA’s Critical Advantage
Peer-reviewed research shows redesigned lipid nanoparticles can reduce toxicity without sacrificing delivery, fueling growing expert inter...
INVESTMENT
18 Jun 2025
Why BioNTech’s CureVac Move Matters Far Beyond Vaccines
BioNTech’s all-share purchase of CureVac sharpens Europe’s focus on mRNA therapies beyond Covid-19
RESEARCH
11 Jun 2025
Europe Builds Momentum Behind Tailored mRNA Cancer Shots
European scientists are sharpening personalized mRNA cancer vaccines, with steady gains in design, delivery, and early clinical testing
REGULATORY
2 Apr 2025
EU Regulator Raises mRNA Vaccine Bar
New EMA draft guidance clarifies standards for mRNA vaccines, prompting cautious interest across Europe
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.